> On Jul 13, 2023, at 8:12 AM, Randy John Read <rj...@cam.ac.uk> wrote:
>
>
> External Email Warning: Do not click links or open attachments unless you 
> recognize the sender and expect the content. UTMB Email Phishing 
> Awareness<https://www.utmb.edu/infosec/resources/phishawareness>
>
> I’m not sure about other methods, but AlphaFold does predict peptides in both 
> cis and trans configurations. In a recent paper, Osnat Herzberg and John 
> Moult show that it was pretty successful in predicting proline cis-peptides, 
> among the novel structures in the CASP15 set of targets 
> (https://www.pnas.org/doi/10.1073/pnas.2221745120).
>

Indeed, back in late 2020, at the CASP14 conference, Osnat showed that the 
AF-predicted model of her protein containing a cis-proline fit the X-ray map 
way better than the model that she built de novo with a trans-proline. 
Considering that these days many (most?) of us are working with 3A+ resolution 
cryoEM maps in which the conformation of the main chain is uncertain (main 
chain oxygen bumps are invisible), the question of trans/cis-prolines is 
omnipresent. Sometimes (most often?) it can be answered with the help of an AF 
model.

> For non-proline cis-peptides, I’m not aware of published work but Tristan 
> Croll has shown me examples of correctly-predicted non-proline cis-peptides, 
> including cases where some of the related structures in the PDB have an 
> incorrect trans configuration. This implies that AlphaFold is not slavishly 
> reproducing what it has seen during training.

Thank you for this note. This is another confirmation that these days we need 
to carefully examine all discrepancies between our de-novo built structures and 
AF models.

Petr Leiman


>
> Best wishes,
>
> Randy Read
>
>> On 13 Jul 2023, at 13:56, Oliviero Carugo <oliviero.car...@univie.ac.at> 
>> wrote:
>>
>> Does anybody know if cis-peptides are predicted by the AI tools (AlphaFold2, 
>> ColabFold, or ESM-2)?
>>
>> ########################################################################
>>
>> To unsubscribe from the CCP4BB list, click the following link:
>> https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
>>
>> This message was issued to members of http://www.jiscmail.ac.uk/CCP4BB, a 
>> mailing list hosted by http://www.jiscmail.ac.uk/, terms & conditions are 
>> available at https://www.jiscmail.ac.uk/policyandsecurity/
>
> -----
> Randy J. Read
> Department of Haematology, University of Cambridge
> Cambridge Institute for Medical Research     Tel: +44 1223 336500
> The Keith Peters Building
> Hills Road                                                       E-mail: 
> rj...@cam.ac.uk
> Cambridge CB2 0XY, U.K.                              
> www-structmed.cimr.cam.ac.uk
>
>
> ########################################################################
>
> To unsubscribe from the CCP4BB list, click the following link:
> https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
>
> This message was issued to members of http://www.jiscmail.ac.uk/CCP4BB, a 
> mailing list hosted by http://www.jiscmail.ac.uk/, terms & conditions are 
> available at https://www.jiscmail.ac.uk/policyandsecurity/


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to